Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gastric Cancer

Free Subscription 08.12.2025 6 Anticancer Res 3 BMC Cancer 1 BMC Gastroenterol 1 BMC Surg 1 Br J Cancer 1 Clin Cancer Res 1 Dig Dis Sci 1 Endoscopy 1 Eur J Surg Oncol 1 J Cancer Res Clin Oncol 1 Minerva Gastroenterol (Torino) 1 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Res

1. LEE SY, Hyung J, Kim HD, Lee H, et al
   Genomic Correlations for Clinical Outcomes in HER2-positive Advanced Gastric Cancer Treated Using Trastuzumab-based Therapy.
   Anticancer Res. 2025;45:5675-5688.
   PubMed         Abstract available
   
   
2. TAKENAKA S, Kimura M, Iwai M, Usami E, et al
   Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving Ramucirumab.
   Anticancer Res. 2025;45:5735-5741.
   PubMed         Abstract available
   
   
3. KOIVUROVA OP, Blomster T, Eskelinen M, Sipponen P, et al
   Uniformity Between Serological Biomarker Test, Esophago-gastro-duodenoscopy and Biopsy Histology in Triage of Upper Abdominal Symptoms in Gastroscopy Referral Patients.
   Anticancer Res. 2025;45:5491-5501.
   PubMed         Abstract available
   
   
4. IKEDA T, Kanaji S, Urakawa N, Harada H, et al
   Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study.
   Anticancer Res. 2025;45:5557-5566.
   PubMed         Abstract available
   
   
5. EBIHARA Y, Kyogoku N, Takano H, Wada H, et al
   Postoperative Complications, Including Minor Complications, Worsen Prognosis After Laparoscopic Distal Gastrectomy for Gastric Cancer.
   Anticancer Res. 2025;45:5619-5631.
   PubMed         Abstract available
   
   
6. HASHIMOTO I, Nakayama Y, Tanabe M, Morita J, et al
   Clinical Utility of the Preoperative Cachexia Index in Patients Undergoing Curative Gastrectomy for Gastric Cancer.
   Anticancer Res. 2025;45:5667-5674.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. CHEN Y, Liu D, Sun K, Lin Y, et al
   Unsupervised machine learning reveals prognostic value of dynamic carbohydrate antigen 125 trajectory in gastric cancer.
   BMC Cancer. 2025;25:1834.
   PubMed         Abstract available
   
   
8. XIN R, Ma X, Niu M, Hao Q, et al
   Comprehensive long-read transcriptomic analysis reveals multi-level transcriptional alterations mediated by miR-214-3p dysregulation in gastric cancer cells.
   BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15323.
   PubMed         Abstract available
   
   
9. LI L, Zhang YH, Wang HJ, Wang YY, et al
   ASPN was higher expression in gastric cancer and associated with poor prognosis through promoting invasion and migration and inducing macrophage M2 polarization.
   BMC Cancer. 2025;25:1851.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. ZHAO G, Liu Y, Wang H, Zhang Y, et al
    Global, regional, and national burden of gastric cancer attributable to smoking and a high-sodium diet from 1990 to 2021: a global burden of disease study 2021.
    BMC Gastroenterol. 2025 Dec 3. doi: 10.1186/s12876-025-04431.
    PubMed         Abstract available
    
    

    
    BMC Surg

11. GUO R, Wu H, Han Z, Zhang L, et al
    The research progress on the application of ICG fluorescence imaging in robotic D2 lymphadenectomy for gastric cancer: a narrative review.
    BMC Surg. 2025;25:580.
    PubMed         Abstract available
    
    

    
    Br J Cancer

12. LI J, Liu L, Tao M, Han Z, et al
    Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.
    Br J Cancer. 2025 Nov 29. doi: 10.1038/s41416-025-03289.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

13. KU G, Shen L, Dayyani F, Kratz J, et al
    A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.
    Clin Cancer Res. 2025;31:4944-4952.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

14. LI Y, Xu L, Lu X, Fu B, et al
    Helicobacter pylori Lipopolysaccharide Upregulates MDM2 via the TLR4/MAPK/AP-1 Pathway to Promote Gastric Cancer Progression.
    Dig Dis Sci. 2025 Nov 29. doi: 10.1007/s10620-025-09576.
    PubMed         Abstract available
    
    

    
    Endoscopy

15. ZHANG R, Ji R, Li M, Yang X, et al
    Safety and efficacy of traction robot-assisted endoscopic submucosal dissection for early gastric cancer: a randomized pilot trial.
    Endoscopy. 2025 Dec 2. doi: 10.1055/a-2699-5861.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

16. SALOBIR J, Sever P, Birk M, Zagar T, et al
    Gastric cancer surgery in high volume university medical centers influences long-term survival.
    Eur J Surg Oncol. 2025;52:111312.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

17. TABNAK P, Ebrahimnezhad M
    Insights into SUMOylation in gastric cancer: molecular mechanisms and emerging therapeutic opportunities.
    J Cancer Res Clin Oncol. 2025;152:2.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

18. COLECCHIA L, Barbara G, Marasco G
    Gastric cancer screening: is gastric microbiota beyond Helicobacter pylori the missing piece to the puzzle?
    Minerva Gastroenterol (Torino). 2025 Dec 4. doi: 10.23736/S2724-5985.25.04035.
    PubMed        
    
    

    
    Surgery

19. WANG H, Espat NJ, Calvino AS, Somasundar P, et al
    Disparities in use and outcomes of robotic surgery for gastric cancer: An evaluation of a large national cohort.
    Surgery. 2025;190:109933.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.